VCRTVenture Capital Roundtable (Haas Entrepreneurs Association)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
20 April 2011 - US-based medical diagnostic company Vicor Technologies Inc (OTC: VCRT) announced yesterday the receipt of 510(k) clearance from the US Food and Drug Administration for its PD2i nonlinear algorithm and software to be used as a measure of heart rate variability at rest, and in response to controlled exercise and paced respiration (Ewing Maneuvers) in patients specifically undergoing cardiovascular disease testing.
14 January 2010 - US-based biotechnology company Vicor Technologies Inc (OTC: VCRT) said today that it has entered into an exclusive distribution agreement for the PD2i Analyzer in South Carolina, North Carolina, and the cities of Savannah and Augusta, Georgia, and sold its first PD2i Analyzer to a US physician.